Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Sanofi and Medtronic to develop drug-device combos in diabetes

Companies tell PMLiVE their new alliance will take an ‘open innovation’ approach

- PMLiVE

ADA: AZ plans to file Onglyza/Forxiga pill by year-end

Diabetes prospects could help justify decision to turn down Pfizer bid

- PMLiVE

Breathing new life into pharma’s innovation engine

The rise of new collaborative approaches to R&D

- PMLiVE

ADA: Lilly/Boehringer insulin glargine matches Lantus

Biosimilar demonstrates equal efficacy to Sanofi’s big-selling diabetes treatment

AbbVie closes in on US approval of all-oral hepatitis C regimen

FDA grants priority review to company’s protease inhibitor ABT-450 regimen

- PMLiVE

Sanofi US takes to Pinterest for more visual sharing

Adds the online pin board to its social media toolkit

- PMLiVE

NHS England takes aim at medicines optimisation

New dashboard to support patients' medicine use has pharma support

- PMLiVE

EMA: We will allow clinical data download

Regulator says it hasn't watered down trial transparency measures

Oncology drugs under AMNOG: part two

Patient-relevant outcomes and the 'added benefit' of cancer drugs

- PMLiVE

Cello Health Insight appoints new digital director

Dan Brilot joins from YouGov

- PMLiVE

AstraZeneca has clearer route to Movantik approval in US

Won't have to carry out cardiovascular outcomes study prior to approval

- PMLiVE

Archimed drug safety specialists rebrand

Changes name to Fishawack Archimed following integration

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links